Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Autoimmune Diseases”

469 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 469 results

Testing effectiveness (Phase 2)Study completedNCT00065260
What this trial is testing

Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia

Who this might be right for
Aplastic Anemia
National Heart, Lung, and Blood Institute (NHLBI) 54
Early research (Phase 1)Not Yet RecruitingNCT06633042
What this trial is testing

The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSD

Who this might be right for
Autoimmune Disease
Bioray Laboratories 18
Early research (Phase 1)Looking for participantsNCT06464679
What this trial is testing

An Exploratory Clinical Study of CD19 CAR NK Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
Changhai Hospital 72
Very early researchWithdrawnNCT07410377
What this trial is testing

UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusInflammatory Myopathy
The Affiliated Hospital of Xuzhou Medical University
Early research (Phase 1)Looking for participantsNCT07021209
What this trial is testing

GT719 Injection for Recurrent/Refractory Antibody-mediated Neurological Immune Diseases

Who this might be right for
Neurological Autoimmune Diseases
Grit Biotechnology 30
Testing effectiveness (Phase 2)Looking for participantsNCT07547930
What this trial is testing

Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease, TEDGraves OphthalmopathyGraves Orbitopathy
The First Affiliated Hospital of Xiamen University 8
Early research (Phase 1)Looking for participantsNCT07361094
What this trial is testing

Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Systemic Lupus ErythematosusRelapsed/Refractory Systemic SclerosisRelapsed/Refractory Idiopathic Inflammatory Myopathies+3 more
Beijing Boren Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT05938725
What this trial is testing

KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

Who this might be right for
Lupus NephritisLupus Nephritis - World Health Organization (WHO) Class IIILupus Nephritis - WHO Class IV
Kyverna Therapeutics 6
Testing effectiveness (Phase 2)Study completedNCT02714959
What this trial is testing

IL-2 in Refractory Autoimmune Encephalitis

Who this might be right for
Encephalitis
Seoul National University Hospital 10
Testing effectiveness (Phase 2)UnknownNCT00698191
What this trial is testing

Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Refractory Systemic Lupus Erythematosus
Nanjing Medical University 20
Very early researchLooking for participantsNCT07526350
What this trial is testing

MTS109 in Patients With Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesSystemic Sclerosis (SSc)+2 more
Shanghai Changzheng Hospital 15
Not applicableLooking for participantsNCT07413835
What this trial is testing

Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG)

Who this might be right for
Refractory Myasthenia Gravis
The Affiliated Hospital of Xuzhou Medical University 6
Large-scale testing (Phase 3)Ended earlyNCT00451867
What this trial is testing

Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . .

Who this might be right for
Interstitial CystitisPainful Bladder Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 210
Post-approval studies (Phase 4)UnknownNCT01405807
What this trial is testing

Alemtuzumab for ANCA Associated Refractory Vasculitis

Who this might be right for
VasculitisMicroscopic PolyangiitisGranulomatosis With Polyangiitis+1 more
Cambridge University Hospitals NHS Foundation Trust 24
Very early researchLooking for participantsNCT07617740
What this trial is testing

IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
Peking University People's Hospital 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07324889
What this trial is testing

An Open-label, Single-arm, Prospective, Multicenter, Phase I/II Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-T Cell Therapy for Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

Who this might be right for
Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia
Yihao Wang 24
Testing effectiveness (Phase 2)Study completedNCT00004643
What this trial is testing

Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
National Center for Research Resources (NCRR) 10
Not applicableEnrolling By InvitationNCT05998291
What this trial is testing

Dermatitis Herpetiformis Refractory to Gluten Free Diet

Who this might be right for
Dermatitis Herpetiformis
Tampere University Hospital 23
Early research (Phase 1)Ended earlyNCT00424489
What this trial is testing

Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Northwestern University 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT06384976
What this trial is testing

KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis+1 more
Kyverna Therapeutics 120
Next Page